edetic acid has been researched along with Lung Diseases, Obstructive in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jones, JG; Minty, BD; Royston, D | 1 |
Maisi, PS; Raulo, SM; Sorsa, TA | 1 |
Eigenbrodt, E; Morr, H; Schneider, J; Velcovsky, HG; Weisse, G | 1 |
1 review(s) available for edetic acid and Lung Diseases, Obstructive
Article | Year |
---|---|
Changes in alveolar-capillary barrier function in animals and humans.
Topics: Animals; Biological Transport, Active; Body Water; Capillaries; Capillary Permeability; Cell Membrane Permeability; Chromium Radioisotopes; Closing Volume; Edetic Acid; Endothelium; Epithelium; Humans; Hydrochloric Acid; Lung; Lung Diseases, Obstructive; Pentetic Acid; Pulmonary Alveoli; Pulmonary Edema; Smoking; Technetium; Technetium Tc 99m Pentetate | 1983 |
2 other study(ies) available for edetic acid and Lung Diseases, Obstructive
Article | Year |
---|---|
Concentrations of elastinolytic metalloproteinases in respiratory tract secretions of healthy horses and horses with chronic obstructive pulmonary disease.
Topics: Animals; Down-Regulation; Edetic Acid; Elastin; Female; Fluorometry; Horse Diseases; Horses; Lung Diseases, Obstructive; Male; Molecular Weight; Protease Inhibitors; Respiratory System; Tetracyclines | 2000 |
Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Enzyme Tests; Disease Progression; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Humans; Isoenzymes; Lung Diseases; Lung Diseases, Obstructive; Lung Neoplasms; Neoplasm Proteins; Pneumoconiosis; Pyruvate Kinase; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2000 |